{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:53:00Z","timestamp":1790621580250,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["950007"],"award-info":[{"award-number":["950007"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cell. Biochem."],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1002\/jcb.25917","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T15:43:06Z","timestamp":1485790986000},"page":"1994-1999","source":"Crossref","is-referenced-by-count":38,"title":["Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy"],"prefix":"10.1002","volume":"118","author":[{"given":"Safieh","family":"Ebrahimi","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry; School of Medicine; Mashhad University of Medical Sciences; Mashhad Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Ghorbani","sequence":"additional","affiliation":[{"name":"Department of Microbiology; Al-Zahra University; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[{"name":"Department of Medical Physiology; School of Medicine; Mashhad University of Medical Sciences; Mashhad Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[{"name":"Metabolic Syndrome Research Center; School of Medicine; Mashhad University of Medical Sciences; Mashhad Iran"},{"name":"Molecular Medicine Group; Department of Modern Sciences and Technologies; School of Medicine Mashhad University of Medical Sciences Mashhad Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Ryzhikov","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology; St. Louis University School of Medicine; Saint Louis Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayhan","family":"Azadmanesh","sequence":"additional","affiliation":[{"name":"Virology Department; Pasteur Institute of Iran; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry; School of Medicine; Mashhad University of Medical Sciences; Mashhad Iran"},{"name":"Metabolic Syndrome Research Center; School of Medicine; Mashhad University of Medical Sciences; Mashhad Iran"},{"name":"Microanatomy Research Center; Mashhad University of Medical Sciences; Mashhad Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"10.1002\/jcb.25917-BIB0001|jcb25917-cit-0001","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1002\/jcb.25917-BIB0002|jcb25917-cit-0002","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1073\/pnas.0912344107","article-title":"Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production","volume":"107","author":"Alain","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jcb.25917-BIB0003|jcb25917-cit-0003","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/JVI.05545-11","article-title":"The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5\/T-BET signaling and generation of gamma interferon","volume":"86","author":"Alvarez-Breckenridge","year":"2012","journal-title":"J Virol"},{"key":"10.1002\/jcb.25917-BIB0004|jcb25917-cit-0004","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","article-title":"The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry","volume":"13","author":"Amini-Bavil-Olyaee","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1002\/jcb.25917-BIB0005|jcb25917-cit-0005","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2013.187","article-title":"Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis","volume":"21","author":"Ben Yebdri","year":"2013","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0006|jcb25917-cit-0006","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JVI.02106-12","article-title":"Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis","volume":"87","author":"Berchtold","year":"2013","journal-title":"J Virol"},{"key":"10.1002\/jcb.25917-BIB0007|jcb25917-cit-0007","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.virol.2015.08.003","article-title":"Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1","volume":"485","author":"Cataldi","year":"2015","journal-title":"Virology"},{"key":"10.1002\/jcb.25917-BIB0008|jcb25917-cit-0008","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ni1008-1097","article-title":"RAPping production of type I interferon in pDCs through mTOR","volume":"9","author":"Costa-Mattioli","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1002\/jcb.25917-BIB0009|jcb25917-cit-0009","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"10.1002\/jcb.25917-BIB0010|jcb25917-cit-0010","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1038\/mto.2016.21","article-title":"Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy","volume":"3","author":"Dold","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"10.1002\/jcb.25917-BIB0011|jcb25917-cit-0011","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/cgt.2013.55","article-title":"Overcoming cancer cell resistance to VSV oncolysis with JAK1\/2 inhibitors","volume":"20","author":"Escobar-Zarate","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"10.1002\/jcb.25917-BIB0012|jcb25917-cit-0012","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1128\/JVI.02744-14","article-title":"Interferon-induced Ifit proteins: Their role in viral pathogenesis","volume":"89","author":"Fensterl","year":"2015","journal-title":"J Virol"},{"key":"10.1002\/jcb.25917-BIB0013|jcb25917-cit-0013","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0605496103","article-title":"Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses","volume":"103","author":"Fulci","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jcb.25917-BIB0014|jcb25917-cit-0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/jir.2010.0111","article-title":"Role of promyelocytic leukemia protein in host antiviral defense","volume":"31","author":"Geoffroy","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1002\/jcb.25917-BIB0015|jcb25917-cit-0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jir.2010.0076","article-title":"Human MxA protein: An interferon-induced dynamin-like GTPase with broad antiviral activity","volume":"31","author":"Haller","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1002\/jcb.25917-BIB0016|jcb25917-cit-0016","first-page":"14","article-title":"Signal transduction in the interferon system","volume":"25","author":"Haque","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1002\/jcb.25917-BIB0017|jcb25917-cit-0017","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ymthe.2006.07.009","article-title":"Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy","volume":"14","author":"Hoti","year":"2006","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0018|jcb25917-cit-0018","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/mt.2011.245","article-title":"Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo","volume":"20","author":"Huang","year":"2012","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0019|jcb25917-cit-0019","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ymthe.2005.07.533","article-title":"The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma","volume":"12","author":"Hummel","year":"2005","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0020|jcb25917-cit-0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I","volume":"147","author":"Isaacs","year":"1957","journal-title":"The interferon. Proc R Soc Lond B Biol Sci"},{"key":"10.1002\/jcb.25917-BIB0021|jcb25917-cit-0021","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/1541-7786.MCR-15-0427","article-title":"STAT1 and NF-kappaB inhibitors diminish basal interferon-stimulated gene expression and improve the productive infection of oncolytic HSV in MPNST cells","volume":"14","author":"Jackson","year":"2016","journal-title":"Mol Cancer Res"},{"key":"10.1002\/jcb.25917-BIB0022|jcb25917-cit-0022","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/PL00000644","article-title":"Gene structure and function of the 2'-5'-oligoadenylate synthetase family","volume":"57","author":"Justesen","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1002\/jcb.25917-BIB0023|jcb25917-cit-0023","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.mt.6300108","article-title":"History of oncolytic viruses: Genesis to genetic engineering","volume":"15","author":"Kelly","year":"2007","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0024|jcb25917-cit-0024","doi-asserted-by":"crossref","first-page":"E204","DOI":"10.1002\/ijc.27404","article-title":"Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: Potential role of human papilloma virus infection","volume":"131","author":"Le Boeuf","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1002\/jcb.25917-BIB0025|jcb25917-cit-0025","doi-asserted-by":"crossref","first-page":"e28683","DOI":"10.1371\/journal.pone.0028683","article-title":"Epigenetic silencing of IRF7 and\/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1002\/jcb.25917-BIB0026|jcb25917-cit-0026","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1074\/jbc.M410972200","article-title":"Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1002\/jcb.25917-BIB0027|jcb25917-cit-0027","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/mt.2011.144","article-title":"Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus","volume":"19","author":"Liikanen","year":"2011","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0028|jcb25917-cit-0028","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/srep02375","article-title":"Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy","volume":"3","author":"Liu","year":"2013","journal-title":"Sci Rep"},{"key":"10.1002\/jcb.25917-BIB0029|jcb25917-cit-0029","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/1079990041689665","article-title":"Induction and regulation of IFNs during viral infections","volume":"24","author":"Malmgaard","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"10.1002\/jcb.25917-BIB0030|jcb25917-cit-0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/mt.2008.201","article-title":"Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3","volume":"16","author":"Marozin","year":"2008","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0031|jcb25917-cit-0031","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virusres.2014.05.025","article-title":"Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness","volume":"189","author":"Parrula","year":"2014","journal-title":"Virus Res"},{"key":"10.1002\/jcb.25917-BIB0032|jcb25917-cit-0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.virol.2012.11.014","article-title":"Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signaling","volume":"436","author":"Moerdyk-Schauwecker","year":"2013","journal-title":"Virology"},{"key":"10.1002\/jcb.25917-BIB0033|jcb25917-cit-0033","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1002\/jcb.25917-BIB0034|jcb25917-cit-0034","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1128\/JVI.05640-11","article-title":"Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma","volume":"86","author":"Murphy","year":"2012","journal-title":"J Virol"},{"key":"10.1002\/jcb.25917-BIB0035|jcb25917-cit-0035","doi-asserted-by":"crossref","first-page":"14981","DOI":"10.1073\/pnas.0803988105","article-title":"Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis","volume":"105","author":"Nguyen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jcb.25917-BIB0036|jcb25917-cit-0036","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coviro.2015.02.003","article-title":"The unique regulation and functions of type III interferons in antiviral immunity","volume":"12","author":"Odendall","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1002\/jcb.25917-BIB0037|jcb25917-cit-0037","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/mt.2008.155","article-title":"Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses","volume":"16","author":"Otsuki","year":"2008","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0038|jcb25917-cit-0038","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1128\/JVI.00723-11","article-title":"Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: Rare resistance is overcome by blocking interferon pathways","volume":"85","author":"Paglino","year":"2011","journal-title":"J Virol"},{"key":"10.1002\/jcb.25917-BIB0039|jcb25917-cit-0039","doi-asserted-by":"crossref","first-page":"20047","DOI":"10.1074\/jbc.R700004200","article-title":"The interferons: 50 years after their discovery, there is much more to learn","volume":"282","author":"Pestka","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1002\/jcb.25917-BIB0040|jcb25917-cit-0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(03)00016-0","article-title":"The p38 mitogen-activated protein kinase pathway and its role in interferon signaling","volume":"98","author":"Platanias","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1002\/jcb.25917-BIB0041|jcb25917-cit-0041","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jcb.25917-BIB0042|jcb25917-cit-0042","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1074\/jbc.271.1.278","article-title":"The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2","volume":"271","author":"Platanias","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1002\/jcb.25917-BIB0043|jcb25917-cit-0043","doi-asserted-by":"crossref","first-page":"9277","DOI":"10.1128\/JVI.01422-14","article-title":"ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle","volume":"88","author":"Rodriguez","year":"2014","journal-title":"J Virol"},{"key":"10.1002\/jcb.25917-BIB0044|jcb25917-cit-0044","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/mto.2015.19","article-title":"Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma","volume":"2","author":"Ruf","year":"2015","journal-title":"Mol Ther Oncolytics"},{"key":"10.1002\/jcb.25917-BIB0045|jcb25917-cit-0045","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/mt.2012.53","article-title":"Interferon-beta sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models","volume":"20","author":"Ruotsalainen","year":"2012","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0046|jcb25917-cit-0046","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jcb.25917-BIB0047|jcb25917-cit-0047","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: A complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1002\/jcb.25917-BIB0048|jcb25917-cit-0048","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat Med"},{"key":"10.1002\/jcb.25917-BIB0049|jcb25917-cit-0049","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/sj.mt.6300273","article-title":"Early STAT1 activation after systemic delivery of HSV amplicon vectors suppresses transcription of the vector-encoded transgene","volume":"15","author":"Suzuki","year":"2007","journal-title":"Mol Ther"},{"key":"10.1002\/jcb.25917-BIB0050|jcb25917-cit-0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ijc.25088","article-title":"Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death","volume":"127","author":"Zhang","year":"2010","journal-title":"Int J Cancer"}],"container-title":["Journal of Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcb.25917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcb.25917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T04:27:55Z","timestamp":1719030475000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcb.25917"}},"subtitle":["I<scp>NTERFERON<\/scp>R<scp>ESPONSES<\/scp>C<scp>ONFER<\/scp>I<scp>NSENSITIVITY<\/scp><scp>TO<\/scp>O<scp>NCOLYTIC<\/scp>V<scp>IROTHERAOY<\/scp><scp>IN<\/scp>T<scp>UMORS<\/scp>"],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/jcb.25917","archive":["Portico"],"relation":{},"ISSN":["0730-2312"],"issn-type":[{"value":"0730-2312","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}